Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
MXCT
#3318
MaxCyte, Inc. Common Stock
0.8
1
+6.58%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
+6.58%
Monatliche Änderung
-23.58%
6 month change
-42.55%
Jahresänderung
-76.45%
Vorheriger Schlusskurs
0.7
6
Open
0.8
1
Bid
Ask
Low
0.8
1
High
0.8
1
Volumen
49
Märkte
Aktien
Gesundheitswesen
MXCT
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
101.51 M
102.9 M
104.13 M
106.03 M
—
Valuation ratios
Enterprise value
986.6 M
515.81 M
474.14 M
413.19 M
1.05 B
Price to earnings ratio
-48.52
-22.26
-13.51
-10.67
-261.3
Price to sales ratio
27.24
11.76
12.51
11.29
30.21
Price to cash flow ratio
-86.46
-35.22
23.81
15.8
35.49
Price to book ratio
3.51
2.05
2.22
2.11
2.96
Enterprise value to EBITDA ratio
-58.85
-20.91
-10.74
-8.81
-22.08
Profitability ratios
Return on assets %
-0.07
-0.08
0.14
0.17
0.2
Return on equity %
-0.07
-0.09
0.16
0.2
0.24
Return on invested capital %
-264.71
-253.73
244.51
223.97
—
Gross margin %
89.24
88.48
88.51
81.62
318.12
Operating margin %
-53.66
-61.82
116.98
132.54
641.19
EBITDA margin %
-49.46
-55.72
-106.88
-121.37
-589.85
Net margin %
-56.3
-53.25
91.85
106.29
547.74
Liquidity ratios
Quick ratio
16.98
15.8
9.97
10.32
40.88
Current ratio
17.32
16.35
10.65
10.88
43.25
Inventory turnover
0.7
0.74
0.46
0.67
0.8
Asset turnover
0.12
0.16
0.15
0.15
0.15
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.12
-0.15
0.21
0.26
0.37
EBIT per share
-0.2
-0.27
-0.47
-0.49
-0.51
EBITDA per share
-0.19
-0.24
-0.43
-0.45
-0.46
Total debt per share
—
—
—
—
—
Cash per share
2.81
2.24
1.63
1.47
4.96
Net current asset value per share
2.98
2.48
1.84
1.64
5.62
Tangible book value per share
2.9
2.5
2.25
1.97
7.21
Working capital per share
2.81
2.33
1.67
1.49
5.09
Book value per share
2.9
2.5
2.25
1.97
7.33
Nachrichten
Cellares appoints Ali Soleymannezhad as chief commercial officer
MaxCyte stellt auf Stephens-Konferenz Neuausrichtung
MaxCyte, Inc. (MXCT) Q3 2025 Earnings Call Transcript
MaxCyte verfehlt Q3-Prognosen – Aktie gibt nach
MaxCyte CFO Douglas Swirsky to step down in first half of 2026
Avidity Biosciences, Inc. (RNA) Reports Q3 Loss, Beats Revenue Estimates
ANI Pharmaceuticals (ANIP) Q3 Earnings and Revenues Beat Estimates
Masoud Maher buys Maxcyte (MXCT) shares worth $102,915
Maxcyte CFO Swirsky buys $64.5k in shares
Brooke William buys Maxcyte (MXCT) shares worth $64,500
Douglas buys $111k in Maxcyte shares
Erck Stanley C, Maxcyte director, buys $137k in MXCT stock